-+ 0.00%
-+ 0.00%
-+ 0.00%
Eton Pharma Chief Business Officer David Krempa sells 4,166 common shares for $229,405.56
Share
Listen to the news
Eton Pharma Chief Business Officer David Krempa sells 4,166 common shares for $229,405.56
  • Eton Pharmaceuticals Chief Business Officer David Krempa sold 4,166 common shares on Oct. 6, 2026 at USD 55.0663.
  • Holdings fell to 43,381 shares following the sale.
  • Earlier, 10,522 shares were acquired on Oct. 2, 2026 via restricted stock unit vesting.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-032240), on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending